Prognostic importance of temozolomide-induced neutropenia in glioblastoma, IDH-wildtype patients
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic importance of temozolomide-induced neutropenia in glioblastoma, IDH-wildtype patients
Authors
Keywords
Neutropenia, Glioblastoma, Temozolomide, Prognosis, IDH
Journal
NEUROSURGICAL REVIEW
Volume 41, Issue 2, Pages 621-628
Publisher
Springer Nature
Online
2017-09-12
DOI
10.1007/s10143-017-0903-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bone marrow response as a potential biomarker of outcomes in glioblastoma patients
- (2017) Eugene J. Vaios et al. JOURNAL OF NEUROSURGERY
- Permeability Surface Area Product Using Perfusion Computed Tomography Is a Valuable Prognostic Factor in Glioblastomas Treated with Radiotherapy Plus Concomitant and Adjuvant Temozolomide
- (2017) Taiichi Saito et al. World Neurosurgery
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients
- (2015) Frede Donskov et al. BRITISH JOURNAL OF CANCER
- Pretreated baseline neutrophil count and chemotherapy-induced neutropenia may be conveniently available as prognostic biomarkers in advanced gastric cancer
- (2015) Z. Chen et al. INTERNAL MEDICINE JOURNAL
- Tumor-Associated Neutrophils as a New Prognostic Factor in Cancer: A Systematic Review and Meta-Analysis
- (2014) Meixiao Shen et al. PLoS One
- Neutrophil-mediated tumour angiogenesis: Subversion of immune responses to promote tumour growth
- (2013) Simon Tazzyman et al. SEMINARS IN CANCER BIOLOGY
- Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, methylight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 g
- (2012) Véronique Quillien et al. CANCER
- Change in platelet levels during radiotherapy with concurrent and adjuvant temozolomide for the treatment of glioblastoma: a novel prognostic factor for survival
- (2012) Matt Williams et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- IDH1 and IDH2 mutations, immunohistochemistry and associations in a series of brain tumors
- (2011) Marta Mellai et al. JOURNAL OF NEURO-ONCOLOGY
- Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma
- (2010) J. J. C. Verhoeff et al. ANNALS OF ONCOLOGY
- Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
- (2010) James R. Perry et al. JOURNAL OF CLINICAL ONCOLOGY
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dose calculation of anticancer drugs
- (2008) Bo Gao et al. Expert Opinion on Drug Metabolism & Toxicology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More